Generics

Amneal is introducing dexamethasone, azacitidine, carboprost and atropine for the institutional market.

Lamotrigine ODT is indicated for epilepsy adjunctive therapy in patients aged 2 years old and older, epilepsy monotherapy in patients aged 16 years old and older, and maintenance of bipolar I disorder.

Digoxin tablets have a market value of roughly $2.1 million for the 12 months ending December 2021, according to IQVIA.

Roflumilast tablets are indicated as a treatment to reduce the risk of COPD exacerbations in patients with severe COPD associated with chronic bronchitis and a history of exacerbations.

The medication is used to treat the symptoms of acute heart failure, hypertensive crisis and controlled hypotension during surgery. 

Generic drugmakers report making adjustments to their supply chains, including changes in transportation and sourcing strategies, as well as confidence in their outlook for the year ahead.

The Food and Drug Administration’s Office of Generic Drugs program funded approximately $20 million in generic drug science and research programs in 2021.

Camber’s generic Emend is available in a dosage strength of 150 mg per vial-single dose.